Skip to content

13F-HR filed by CVS HEALTH Corp

CVS HEALTH Corp filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-10, with 7 holding rows worth $104,086,000.

Accession
0000947871-22-001160
Filed
2022-11-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 7 entries on the cover page, a total value of $104,086,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $104,086,000 with VALUE read as thousands by filing date, 13F file number 028-22498. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ISHARES TR46429B663CORE HIGH DV ETF624,536$57,014,000thousands by filing date
Vanguard High Dividend Yield ETF921946406SHS212,832$20,194,000thousands by filing date
SCHD808524797COM297,006$19,730,000thousands by filing date
LUMIRADX LTDg5709l117WT5,352,106$5,459,000thousands by filing date
MP MATERIALS CORP553368101COM CL A41,961$1,146,000thousands by filing date
HEALTH CATALYST INC42225T107COM32,273$313,000thousands by filing date
PRUDENTIAL FINL INC COM744320102Stock2,683$230,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000947871-22-001160this filing2022-11-10acceptance time not in the bulk data set